GENE MUTATIONS AND COPY NUMBER ALTERATIONS (CNA) PREDICT FOR EARLY FAILURE IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH R‐CHOP. (June 2017) - Dlouhy, I.; Karube, K.; Enjuanes, A.; Salaverría, I.; Pérez‐Galán, P.; Jares, P.; Martín‐García, D.; Nadeu, F.; Rivas‐Delgado, A.; Rovira, J.; Gonzalez, B.; Mozos, A.; et al.